Morito (TSE:9837) has put fresh numbers on the table for Q2 2026, with revenue of ¥16.4 billion and net income of ¥984.7 million, translating to basic EPS of ¥39.23. The company has seen quarterly revenue range from ¥12.2 billion in Q1 2025 to ¥16.7 billion in Q1 2026, while basic EPS has moved between a loss of ¥3.77 per share in Q4 2025 and ¥67.08 per share in Q2 2025. This sets a mixed backdrop for the latest print. With forecasts pointing to earnings growth but recent margins and dividend coverage under pressure, this set of results puts profitability quality and margin resilience squarely in focus for investors.
See our full analysis for Morito.With the latest figures on the board, the next step is to see how these earnings line up against the widely held narratives about Morito's growth potential, risk profile, and margin direction.
Curious how numbers become stories that shape markets? Explore Community Narratives
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Morito's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
Given the mix of pressure points and brighter spots around Morito, it makes sense to look at the underlying data yourself and move quickly to shape an informed view. A good place to start is the 1 key reward and 2 important warning signs.
Morito's thinner 3.4% net margin, uneven quarterly earnings and dividend that is not well covered by free cash flow highlight pressure on resilience and income reliability.
If that mix of tight margins and a stretched payout makes you cautious, it is worth shifting some research time toward companies in the solid balance sheet and fundamentals stocks screener (37 results) that pair stronger financial footing with more robust cash support for dividends.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com